ARCHIVES

Also New AACR President Lynn Matrisian plans emphasis on enhancing communication.

This article is from The Cancer Letter archive.

Vol. 30 No. 14 | April 2, 2004

Download PDF Visit The Full Archive

Related Articles

Harlow, Abeloff To Chair BSC Subcommittees; Livingston To Head Extramural Advisors

September 15, 1995

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012

Skin Cancer Screens Find “Extraordinary High” Rates

September 20, 1985

Varmus: NCI Needs To Rethink, Review; Programs Must Be “At A High Level”

November 12, 2010

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983